Mansoura University at IDWeek 2026

Oct 21–24, 2026 Washington, DC ~12k attendees Website

Mansoura University brings 3 presentations to IDWeek 2026 in Washington. Its program centres on comparing antibiotic treatments and HIV prevention options through pooled study analyses. One analysis weighs ceftolozane-tazobactam plus metronidazole against meropenem for complicated abdominal infections.

OrganizationIDWeek 2026 Attendance
Mansoura University
Mansoura, Egypt
Poster
Thu Oct 22
12:15pm–1:30pm
Ceftolozane/Tazobactam Plus Metronidazole Versus Meropenem for Complicated Intra-abdominal Infections: A Systematic Review and Meta-Analysis
Poster Hall B-C · Poster P-136
A4. Treatment of antimicrobial resistant infections
Poster
Thu Oct 22
12:15pm–1:30pm
Evaluating the Arrhythmic Risk of Carbapenems: A Real-World Safety Study
Virtual presentation
J2. Medical Records & Informatics
Poster
Fri Oct 23
12:15pm–1:30pm
Comparative Effectiveness of Long-Acting and Oral Pre-Exposure Prophylaxis for HIV Prevention: A Network Meta-Analysis
Poster Hall B-C · Poster P-979
H2. HIV: Prevention

Explore the full IDWeek 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Washington. Leave your work email and we’ll be in touch.

Privacy

Download the full IDWeek 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Mansoura University

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by IDWeek, the Infectious Diseases Society of America (IDSA) or its partner societies (SHEA, HIVMA, PIDS and SIDP). Submit a correction